CGEN
Compugen Ltd.
NASDAQ · ILHealthcareBiotechnology
$2.34-1.27%
Price as of Jul 20, 2026
CGEN profitability
Compugen Ltd. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 88.1%
- EBITDA margin
- 48.0%
- EBIT margin
- 42.3%
- Net margin
- 48.0%
- Free cash flow margin
- 0.0%
Returns
- Return on equity
- 36.6%
- Return on assets
- 23.9%
- Return on invested capital
- 31.2%
- Asset turnover
- 0.48x
Cash efficiency
- Cash from operations
- $0.00
- Cash per share
- $1.43
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.